X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-06 | TWLO | Twilio Inc | Shipchandler Khozema | CEO | S - Sale | $134.28 | -13,336 | 193,781 | -6% | -$1,790,778 | ||||||
| D | 2026-01-08 | ALKS | Alkermes Plc. | Hopkinson Craig C. | EVP R, D, Chief Medical Office | S - Sale+OE | $30.00 | -5,000 | 61,740 | -7% | -$150,005 | |||||
| M | 2026-01-06 | INSM | Insmed Inc | Adsett Roger | COO | S - Sale | $174.06 | -4,290 | 107,601 | -4% | -$746,711 | |||||
| M | 2026-01-06 | INSM | Insmed Inc | Bonstein Sara | CFO | S - Sale | $174.22 | -4,642 | 80,506 | -5% | -$808,733 | |||||
| DM | 2026-01-06 | INSM | Insmed Inc | Flammer Martina M.D. | Chief Medical Officer | S - Sale+OE | $174.06 | -16,530 | 86,794 | -16% | -$2,877,139 | |||||
| M | 2026-01-06 | PTCT | Ptc Therapeutics, Inc. | Utter Christine Marie | SVP, CHIEF ACCOUNTING OFFICER | S - Sale | $77.19 | -2,616 | 73,727 | -3% | -$201,919 | |||||
2026-01-06 | PTCT | Ptc Therapeutics, Inc. | Gravier Pierre | CFO | S - Sale | $76.95 | -2,139 | 90,310 | -2% | -$164,596 | ||||||
| M | 2026-01-06 | PTCT | Ptc Therapeutics, Inc. | Pauwels Eric | CHIEF BUSINESS OFFICER | S - Sale | $77.18 | -3,141 | 87,489 | -3% | -$242,417 | |||||
| M | 2026-01-06 | PTCT | Ptc Therapeutics, Inc. | Klein Matthew B. | CEO | S - Sale | $77.15 | -8,165 | 396,967 | -2% | -$629,895 | |||||
| M | 2026-01-06 | PTCT | Ptc Therapeutics, Inc. | Golden Lee Scott | EVP, CHIEF MEDICAL OFFICER | S - Sale | $77.12 | -1,982 | 93,294 | -2% | -$152,855 | |||||
| M | 2026-01-06 | INSM | Insmed Inc | Lewis William | Chair, CEO | S - Sale | $174.03 | -9,676 | 599,831 | -2% | -$1,683,950 | |||||
| DM | 2026-01-06 | PTCT | Ptc Therapeutics, Inc. | Boulding Mark Elliott | EVP, CLO | S - Sale+OE | $77.31 | -6,618 | 117,659 | -5% | -$511,641 | |||||
| M | 2026-01-06 | PTCT | Ptc Therapeutics, Inc. | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | S - Sale | $77.19 | -2,411 | 122,927 | -2% | -$186,098 | |||||
| M | 2026-01-06 | INSM | Insmed Inc | Smith Michael Alexander | GC | S - Sale | $174.00 | -3,158 | 57,037 | -5% | -$549,494 | |||||
2026-01-07 | SNPS | Synopsys Inc | Lee Janet | GC, Corporate Secretary | S - Sale | $510.00 | -250 | 12,209 | -2% | -$127,500 | ||||||
| D | 2026-01-07 | COMP | Compass, Inc. | Wahlers Scott R. | CFO | S - Sale+OE | $12.03 | -99,986 | 250,073 | -29% | -$1,202,602 | |||||
| D | 2026-01-07 | LIND | Lindblad Expeditions Holdings, Inc. | Bressler Benjamin | *Founder, CEO of NHA | S - Sale+OE | $15.04 | -29,628 | 23,466 | -56% | -$445,605 | |||||
2026-01-08 | PATH | Uipath, Inc. | Dines Daniel | CEO, COB, 10% | S - Sale | $17.49 | -45,000 | 37,868,882 | 0% | -$787,190 | ||||||
| M | 2026-01-07 | FLOC | Flowco Holdings Inc. | Roberts Chad | EVP, Production Solutions | S - Sale | $19.34 | -23,500 | 170,898 | -12% | -$454,522 | |||||
2026-01-07 | EVER | Everquote, Inc. | Brainard David | CTO | S - Sale | $25.05 | -5,709 | 101,603 | -5% | -$143,010 | ||||||
2026-01-07 | INTU | Intuit Inc. | Goodarzi Sasan K | CEO, Pres, Dir | S - Sale | $650.10 | -41,000 | 13,611 | -75% | -$26,653,960 | ||||||
2026-01-06 | COF | Capital One Financial Corp | Cooper Matthew W | GC, Corp Secy | S - Sale | $250.00 | -2,000 | 92,486 | -2% | -$500,000 | ||||||
2026-01-06 | LMND | Lemonade, Inc. | Peters John Sheldon | Chief Insurance Officer | S - Sale | $80.00 | -10,000 | 60,771 | -14% | -$800,000 | ||||||
2026-01-06 | S | Sentinelone, Inc. | Larson Barbara A | CFO | S - Sale | $14.82 | -11,173 | 539,372 | -2% | -$165,584 | ||||||
2026-01-06 | S | Sentinelone, Inc. | Pinczuk Ana G. | Pres Product, Technology | S - Sale | $14.82 | -11,900 | 560,589 | -2% | -$176,358 | ||||||
| D | 2026-01-07 | QSR | Restaurant Brands International Inc. | Granat Jill | See Remarks | S - Sale+OE | $67.44 | -1,925 | 458,280 | 0% | -$129,828 | |||||
| D | 2026-01-07 | QSR | Restaurant Brands International Inc. | Kobza Joshua | CEO | S - Sale+OE | $67.44 | -3,443 | 952,620 | 0% | -$232,220 | |||||
| D | 2026-01-07 | QSR | Restaurant Brands International Inc. | Schwan Axel | Pres, Tim Hortons Americas | S - Sale+OE | $67.44 | -2,187 | 164,653 | -1% | -$147,475 | |||||
| D | 2026-01-07 | QSR | Restaurant Brands International Inc. | Fulton Duncan | Chief Corporate Officer | S - Sale+OE | $67.48 | -1,775 | 40,728 | -4% | -$119,799 | |||||
| D | 2026-01-07 | QSR | Restaurant Brands International Inc. | Housman Jeffrey | See Remarks | S - Sale+OE | $67.44 | -1,483 | 148,086 | -1% | -$100,043 | |||||
| DM | 2026-01-06 | KVYO | Klaviyo, Inc. | Bialecki Andrew | Co-CEO, 10% | S - Sale+OE | $29.03 | -154,153 | 0 | -100% | -$4,475,299 | |||||
2026-01-07 | AIP | Arteris, Inc. | Hawkins Nicholas B. | VP, CFO | S - Sale | $17.27 | -5,836 | 82,267 | -7% | -$100,799 | ||||||
2026-01-06 | AIP | Arteris, Inc. | Janac K Charles | Pres, CEO, 10% | S - Sale | $16.90 | -11,145 | 9,664,810 | 0% | -$188,386 | ||||||
2026-01-07 | ADI | Analog Devices Inc | Nakamura Katsufumi | SVP, Chief Customer Officer | S - Sale | $289.17 | -500 | 13,210 | -4% | -$144,583 | ||||||
2026-01-06 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO | S - Sale | $16.50 | -35,198 | 2,449,437 | -1% | -$580,767 | ||||||
2026-01-06 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO | S - Sale | $6.82 | -23,766 | 323,530 | -7% | -$162,077 | ||||||
2026-01-06 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Secretary | S - Sale | $16.50 | -17,218 | 806,577 | -2% | -$284,097 | ||||||
2026-01-06 | RIVN | Rivian Automotive, Inc. / De | Scaringe Robert J | CEO | S - Sale | $19.55 | -17,450 | 3,767,722 | 0% | -$341,071 | ||||||
| D | 2026-01-06 | OSCR | Oscar Health, Inc. | Schlosser Mario | Pres of Technology, CTO | S - Sale+OE | $17.01 | -76,962 | 350,180 | -18% | -$1,309,124 | |||||
2026-01-06 | VSAT | Viasat Inc | Dankberg Mark D | COB, CEO | S - Sale | $40.34 | -100,000 | 1,440,889 | -6% | -$4,033,740 | ||||||
| D | 2026-01-07 | ANAB | Anaptysbio, Inc | Loumeau Eric J | GC | S - Sale+OE | $45.56 | -9,639 | 9,157 | -51% | -$439,200 | |||||
| D | 2026-01-07 | ANAB | Anaptysbio, Inc | Lizzul Paul F. | Chief Medical Officer | S - Sale+OE | $45.11 | -2,235 | 37,213 | -6% | -$100,821 | |||||
| D | 2026-01-07 | ANAB | Anaptysbio, Inc | Faga Daniel | Pres, CEO | S - Sale+OE | $45.11 | -9,202 | 466,787 | -2% | -$415,102 | |||||
| D | 2026-01-06 | ADP | Automatic Data Processing Inc | Kwon David | Corp VP | S - Sale+OE | $260.00 | -900 | 11,993 | -7% | -$234,000 | |||||
| D | 2026-01-06 | VRTX | Vertex Pharmaceuticals Inc / Ma | Wagner Charles F Jr | EVP, CO, FO | S - Sale+OE | $461.00 | -9,532 | 37,725 | -20% | -$4,394,252 | |||||
2026-01-07 | TEAM | Atlassian Corp | Cannon-Brookes Michael | CEO, Co-Founder, 10% | S - Sale | $161.11 | -7,665 | 436,905 | -2% | -$1,234,934 | ||||||
2026-01-07 | INCY | Incyte Corp | Issa Mohamed Khairie | EVP, Head of US Oncology | S - Sale | $109.07 | -10,856 | 66,132 | -14% | -$1,184,064 | ||||||
2026-01-06 | NDAQ | Nasdaq, Inc. | Zecca John | EVP, Global CLO | S - Sale | $100.01 | -4,500 | 125,674 | -3% | -$450,045 | ||||||
| D | 2026-01-07 | RMD | Resmed Inc | Farrell Michael J. | COB, CEO | S - Sale+OE | $248.46 | -4,991 | 468,313 | -1% | -$1,240,065 | |||||
| D | 2026-01-06 | MMSI | Merit Medical Systems Inc | Peterson Neil W. | COO | S - Sale+OE | $90.00 | -5,000 | 28,369 | -15% | -$450,000 | |||||
2026-01-08 | AIR | Aar Corp | Garascia Jessica A. | SVP, GC, CAO, Secretary | S - Sale | $95.25 | -4,787 | 29,557 | -14% | -$455,975 | ||||||
2026-01-06 | DRI | Darden Restaurants Inc | Martin Melvin John | Group Pres | S - Sale | $197.47 | -1,200 | 17,229 | -7% | -$236,964 | ||||||
| M | 2026-01-05 | PR | Permian Resources Corp | Oliphint Guy M | EVP, CFO | S - Sale | $13.69 | -301,741 | 616,683 | -33% | -$4,129,479 | |||||
| DM | 2026-01-05 | PR | Permian Resources Corp | Shannon Robert Regan | EVP, Chief Accounting Officer | S - Sale+OE | $13.68 | -176,659 | 2,360,667 | -7% | -$2,416,995 | |||||
| DM | 2026-01-05 | PR | Permian Resources Corp | Walter James H | Co-CEO | S - Sale+OE | $13.67 | -777,703 | 13,052,819 | -6% | -$10,634,192 | |||||
| DM | 2026-01-05 | PR | Permian Resources Corp | Hickey William M III | Co-CEO | S - Sale+OE | $13.67 | -777,705 | 13,277,817 | -6% | -$10,634,217 | |||||
| DM | 2026-01-05 | PR | Permian Resources Corp | Bell John Charles | EVP, GC | S - Sale+OE | $13.68 | -176,648 | 1,729,685 | -9% | -$2,416,845 | |||||
2026-01-05 | TECTP | Tectonic Financial, Inc. | Sherman A Haag | CEO, 10% | S - Sale | $5.70 | -20,000 | 2,101,000 | -1% | -$114,000 | ||||||
2026-01-05 | SNAP | Snap Inc | Spiegel Evan | CEO, 10% | S - Sale | $8.25 | -1,220,165 | 28,515,118 | -4% | -$10,066,361 | ||||||
2026-01-05 | ADPT | Adaptive Biotechnologies Corp | Robins Chad M | CEO, COB | S - Sale | $15.59 | -124,998 | 2,584,243 | -5% | -$1,948,719 | ||||||
| M | 2026-01-06 | CCB | Coastal Financial Corp | Sprink Eric M | CEO | S - Sale | $116.69 | -11,000 | 184,969 | -6% | -$1,283,594 | |||||
| D | 2026-01-05 | PPTA | Perpetua Resources Corp. | Lyon McKinsey Margaret | (See remarks (4)) | S - Sale+OE | $26.61 | -32,490 | 96,664 | -25% | -$864,559 | |||||
| D | 2026-01-05 | CRWV | Coreweave, Inc. | McBee Brannin | Chief Development Officer | S - Sale+OE | $79.28 | -8,835 | 58,800 | -13% | -$700,454 | |||||
| D | 2026-01-05 | CRWV | Coreweave, Inc. | McBee Brannin | Chief Development Officer | S - Sale+OE | $79.28 | -27,000 | 0 | -100% | -$2,140,616 | |||||
| D | 2026-01-05 | CRWV | Coreweave, Inc. | McBee Brannin | Chief Development Officer | S - Sale+OE | $79.28 | -130,835 | 248,664 | -34% | -$10,372,925 | |||||
| D | 2026-01-06 | NTSK | Netskope Inc | Del Matto Andrew H | CFO | S - Sale+OE | $17.16 | -49,875 | 41,493 | -55% | -$855,765 | |||||
| DM | 2026-01-06 | NTSK | Netskope Inc | Beri Sanjay | CEO, COB | S - Sale+OE | $17.20 | -210,076 | 0 | -100% | -$3,612,827 | |||||
| D | 2026-01-05 | CBLL | Ceribell, Inc. | Foehr David | SVP, Finance, PAO | S - Sale+OE | $22.60 | -5,556 | 18,900 | -23% | -$125,566 | |||||
| D | 2026-01-05 | CVX | Chevron Corp | Wirth Michael K | COB, CEO | S - Sale+OE | $162.99 | -320,700 | 50,969 | -86% | -$52,271,978 | |||||
2026-01-06 | PUBM | Pubmatic, Inc. | Klimenko Paulina | Chief Growth Officer | S - Sale | $8.73 | -12,315 | 51,780 | -19% | -$107,509 | ||||||
| DM | 2026-01-05 | AXSM | Axsome Therapeutics, Inc. | Tabuteau Herriot | CEO, 10% | S - Sale+OE | $171.30 | -139,414 | 7,351,729 | -2% | -$23,881,618 | |||||
2026-01-05 | WDAY | Workday, Inc. | Eschenbach Carl M. | CEO | S - Sale | $210.00 | -3,125 | 651,308 | 0% | -$656,250 | ||||||
| D | 2026-01-05 | CVX | Chevron Corp | Bonner Eimear P | CFO | S - Sale+OE | $165.05 | -28,334 | 4,774 | -86% | -$4,676,527 | |||||
2026-01-05 | FFIV | F5, Inc. | Fountain Thomas Dean | EVP Global Services, Strategy | S - Sale | $263.79 | -1,110 | 13,623 | -8% | -$292,807 | ||||||
| D | 2026-01-05 | NAMS | Newamsterdam Pharma Co N.V. | Kastelein Johannes Jacob Pieter | Chief Scientific Officer | S - Sale+OE | $33.25 | -6,000 | 98,981 | -6% | -$199,500 | |||||
| D | 2026-01-05 | NAMS | Newamsterdam Pharma Co N.V. | Somaiya Mayur Ian | CFO | S - Sale+OE | $33.25 | -5,118 | 58,382 | -8% | -$170,174 | |||||
2026-01-05 | TEM | Tempus Ai, Inc. | Fukushima Ryan | COO | S - Sale | $64.26 | -5,000 | 852,754 | -1% | -$321,300 | ||||||
2026-01-05 | META | Meta Platforms, Inc. | Olivan Javier | COO | S - Sale | $650.41 | -517 | 122,419 | 0% | -$336,262 | ||||||
| D | 2026-01-07 | MUSA | Murphy USA Inc. | West Malynda K | Pres, CEO | S - Sale+OE | $425.00 | -4,051 | 118,262 | -3% | -$1,721,675 | |||||
| D | 2026-01-05 | CBLL | Ceribell, Inc. | Chao Xingjuan | Pres, CEO | S - Sale+OE | $21.27 | -79,000 | 1,110,336 | -7% | -$1,680,048 | |||||
| DM | 2026-01-05 | AIP | Arteris, Inc. | Alpern Paul L | VP, GC | S - Sale+OE | $16.56 | -6,818 | 57,650 | -11% | -$112,937 | |||||
| D | 2026-01-05 | CVX | Chevron Corp | Knowles Alana K | Controller | S - Sale+OE | $165.05 | -7,956 | 14,131 | -36% | -$1,313,138 | |||||
| D | 2026-01-05 | QS | Quantumscape Corp | Holme Timothy | CTO | S - Sale+OE | $11.28 | -211,362 | 1,251,383 | -14% | -$2,383,745 | |||||
| D | 2026-01-05 | AFRM | Affirm Holdings, Inc. | Levchin Max R | CEO, 10% | S - Sale+OE | $80.62 | -666,666 | 735,294 | -48% | -$53,747,814 | |||||
| D | 2026-01-05 | AFRM | Affirm Holdings, Inc. | O'Hare Robert | CFO | S - Sale+OE | $80.00 | -36,401 | 1,368 | -96% | -$2,912,080 | |||||
2026-01-05 | MRVL | Marvell Technology, Inc. | Casper Mark | EVP, GC | S - Sale | $93.08 | -5,000 | 36,581 | -12% | -$465,400 | ||||||
| D | 2026-01-05 | NCNO | Ncino, Inc. | Desmond Sean | CEO, Pres | S - Sale+OE | $24.51 | -7,331 | 618,597 | -1% | -$179,683 | |||||
| DM | 2026-01-05 | NUVL | Nuvalent, Inc. | Pelish Henry E. | Chief Scientific Officer | S - Sale+OE | $97.24 | -5,160 | 83,388 | -6% | -$501,753 | |||||
| DM | 2026-01-05 | NUVL | Nuvalent, Inc. | Noci Darlene | Chief Development Officer | S - Sale+OE | $97.25 | -7,417 | 58,117 | -11% | -$721,320 | |||||
| DM | 2026-01-05 | NUVL | Nuvalent, Inc. | Miller Deborah Ann | GC | S - Sale+OE | $97.26 | -6,952 | 59,634 | -10% | -$676,158 | |||||
| DM | 2026-01-05 | NUVL | Nuvalent, Inc. | Turner Christopher Durant | Chief Medical Officer | S - Sale+OE | $97.25 | -7,417 | 72,630 | -9% | -$721,320 | |||||
| DM | 2026-01-05 | NUVL | Nuvalent, Inc. | Balcom Alexandra | CFO | S - Sale+OE | $97.25 | -7,417 | 99,233 | -7% | -$721,320 | |||||
| DM | 2026-01-05 | NUVL | Nuvalent, Inc. | Porter James Richard | Pres, CEO | S - Sale+OE | $97.26 | -27,433 | 324,879 | -8% | -$2,668,260 | |||||
2026-01-06 | WDAY | Workday, Inc. | Kazmaier Gerrit S | Pres, Prod., Tech. | S - Sale | $208.73 | -3,759 | 105,167 | -3% | -$784,626 | ||||||
2026-01-05 | WDAY | Workday, Inc. | Enslin Robert | Pres, CCO | S - Sale | $210.17 | -22,185 | 106,330 | -17% | -$4,662,713 | ||||||
2026-01-06 | WDAY | Workday, Inc. | Rowe Zane | CFO | S - Sale | $208.75 | -6,000 | 159,158 | -4% | -$1,252,492 | ||||||
2026-01-06 | WDAY | Workday, Inc. | Sauer Richard Harry | GC, Secty | S - Sale | $210.00 | -1,130 | 85,398 | -1% | -$237,300 | ||||||
| D | 2026-01-05 | CRNX | Crinetics Pharmaceuticals, Inc. | Kalofonos Isabel | Chief Commercial Officer | S - Sale+OE | $55.00 | -2,500 | 834 | -75% | -$137,500 | |||||
| DM | 2026-01-05 | HGTY | Hagerty, Inc. | Ahn Kenneth | Pres, Hagerty Marketplace | S - Sale+OE | $12.83 | -200,000 | 113,593 | -64% | -$2,565,685 | |||||
2026-01-07 | ACN | Accenture Plc | Macchi Mauro | CEO-EMEA | S - Sale | $280.00 | -500 | 7,623 | -6% | -$140,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |